• Login
    View Item 
    •   Repository Home
    • Journal Articles
    • College of Health Sciences (CHS)
    • View Item
    •   Repository Home
    • Journal Articles
    • College of Health Sciences (CHS)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions.

    Thumbnail
    View/Open
    Abstract.pdf (7.739Kb)
    Date
    2008-01
    Author
    Muchohi, SN
    Obiero, K
    Newton, CR
    Ogutu, BR
    Edwards, G
    Kokwaro, GO
    Metadata
    Show full item record
    Abstract
    AIM: To investigate the pharmacokinetics and clinical efficacy of intravenous (i.v.) and intramuscular (i.m.) lorazepam (LZP) in children with severe malaria and convulsions. METHODS: Twenty-six children with severe malaria and convulsions lasting > or =5 min were studied. Fifteen children were given a single dose (0.1 mg kg(-1)) of i.v. LZP and 11 received a similar i.m. dose. Blood samples were collected over 72 h for determination of plasma LZP concentrations. Plasma LZP concentration-time data were fitted using compartmental models. RESULTS: Median [95% confidence interval (CI)] LZP concentrations of 65.1 ng ml(-1) (50.2, 107.0) and 41.4 ng ml(-1) (22.0, 103.0) were attained within median (95% CI) times of 30 min (10, 40) and 25 min (20, 60) following i.v. and i.m. administration, respectively. Concentrations were maintained above the reported therapeutic concentration (30 ng ml(-1)) for at least 8 h after dosing via either route. The relative bioavailability of i.m. LZP was 89%. A single dose of LZP was effective for rapid termination of convulsions in all children and prevention of seizure recurrence for >72 h in 11 of 15 children (73%, i.v.) and 10 of 11 children (91%, i.m), without any clinically apparent respiratory depression or hypotension. Three children (12%) died. CONCLUSION: Administration of LZP (0.1 mg kg(-1)) resulted in rapid achievement of plasma LZP concentrations within the reported effective therapeutic range without significant cardiorespiratory effects. I.m administration of LZP may be more practical in rural healthcare facilities in Africa, where venous access may not be feasible.
    URI
    http://www.ncbi.nlm.nih.gov/pubmed/17635501
    http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/57762
    Collections
    • College of Health Sciences (CHS) [9505]

    UoN Digital Archive copyright © 2002-2015  Library Department
    Contact Us | Send Feedback
     

     

    Browse

    All of RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    UoN Digital Archive copyright © 2002-2015  Library Department
    Contact Us | Send Feedback